These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28924979)

  • 1. Quantification of Etoposide Hypersensitivity: A Sensitive, Functional Method for Assessing Pluripotent Stem Cell Quality.
    Secreto FJ; Li X; Smith AJ; Bruinsma ES; Perales-Clemente E; Oommen S; Hawse G; Hrstka SCL; Arendt BK; Brandt EB; Wigle DA; Nelson TJ
    Stem Cells Transl Med; 2017 Oct; 6(10):1829-1839. PubMed ID: 28924979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
    Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
    Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem Cell-Derived Microvesicles Transmit RNAs and Proteins to Recipient Mature Heart Cells Modulating Cell Fate and Behavior.
    Bobis-Wozowicz S; Kmiotek K; Sekula M; Kedracka-Krok S; Kamycka E; Adamiak M; Jankowska U; Madetko-Talowska A; Sarna M; Bik-Multanowski M; Kolcz J; Boruczkowski D; Madeja Z; Dawn B; Zuba-Surma EK
    Stem Cells; 2015 Sep; 33(9):2748-61. PubMed ID: 26031404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term self-renewal of human pluripotent stem cells on peptide-decorated poly(OEGMA-co-HEMA) brushes under fully defined conditions.
    Deng Y; Zhang X; Zhao X; Li Q; Ye Z; Li Z; Liu Y; Zhou Y; Ma H; Pan G; Pei D; Fang J; Wei S
    Acta Biomater; 2013 Nov; 9(11):8840-50. PubMed ID: 23891809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of CD34 Fluorescent Reporter Human Induced Pluripotent Stem Cells for Monitoring Hematopoietic Differentiation.
    Husa AM; Strobl MR; Strajeriu A; Wieser M; Strehl S; Fortschegger K
    Stem Cells Dev; 2018 Oct; 27(19):1376-1384. PubMed ID: 30009677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes.
    Ishii MN; Yamamoto K; Shoji M; Asami A; Kawamata Y
    Toxicology; 2017 Aug; 389():130-138. PubMed ID: 28666936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of an undifferentiated state of human-induced pluripotent stem cells through botulinum hemagglutinin-mediated regulation of cell behavior.
    Shuzui E; Kim MH; Azuma K; Fujinaga Y; Kino-Oka M
    J Biosci Bioeng; 2019 Jun; 127(6):744-751. PubMed ID: 30660482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the Potential of Human-Induced Pluripotent Stem Cells: Cellular Responses and Secretome Profiles in Peptide Hydrogel 3D Culture.
    Cui M; Wu W; Li Q; Qi G; Liu X; Bai J; Chen M; Li P; Sun XS
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the susceptibility of neurons and neural stem/progenitor cells derived from human induced pluripotent stem cells to anticancer drugs.
    Fukusumi H; Handa Y; Shofuda T; Kanemura Y
    J Pharmacol Sci; 2019 Aug; 140(4):331-336. PubMed ID: 31501056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
    Tesarova L; Simara P; Stejskal S; Koutna I
    PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?
    Assou S; Bouckenheimer J; De Vos J
    Stem Cells; 2018 Jun; 36(6):814-821. PubMed ID: 29441649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones.
    Dambrot C; Buermans HP; Varga E; Kosmidis G; Langenberg K; Casini S; Elliott DA; Dinnyes A; Atsma DE; Mummery CL; Braam SR; Davis RP
    Exp Cell Res; 2014 Oct; 327(2):297-306. PubMed ID: 24836851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
    Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
    Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of human embryonic and induced pluripotent stem cells to a topoisomerase II poison etoposide.
    Velichko AK; Lagarkova MA; Philonenko ES; Kiselev SL; Kantidze OL; Razin SV
    Cell Cycle; 2011 Jun; 10(12):2035-7. PubMed ID: 21673500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.